INDICATORS OF PHAGOCYTIC ACTIVITY OF MONOCYTES AND CYTOKINE PROFILE IN PATIENTS WITH ERYSIPELAS OF VARYING SEVERITY
Erysipelas (PB) — a serious disease that is accompanied by severe complications and high lethality. The immunological investigations were carry out in 51 patients who were treated at the clinic for erysipelas with an immunomodulator application. Marked changes in the indices of phagocytic activity of monocytes (PHAM) and the cytokine profile in patients with erysipelas were note. Application in complex treatment ofimmunomodulator give the positive effect on the indices of PHAM.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2016 |
|---|---|
| Enthalten in: |
Klinichna khirurhiia - (2016), 7 vom: 26., Seite 54-7 |
| Sprache: |
Ukrainisch |
|---|
| Beteiligte Personen: |
Belyaeva, O A [VerfasserIn] |
|---|
| Themen: |
Angiogenesis Inducing Agents |
|---|
| Anmerkungen: |
Date Completed 30.10.2018 Date Revised 30.10.2018 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM288925734 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM288925734 | ||
| 003 | DE-627 | ||
| 005 | 20231225061425.0 | ||
| 007 | tu | ||
| 008 | 231225s2016 xx ||||| 00| ||ukr c | ||
| 028 | 5 | 2 | |a pubmed24n0963.xml |
| 035 | |a (DE-627)NLM288925734 | ||
| 035 | |a (NLM)30256595 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a ukr | ||
| 100 | 1 | |a Belyaeva, O A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a INDICATORS OF PHAGOCYTIC ACTIVITY OF MONOCYTES AND CYTOKINE PROFILE IN PATIENTS WITH ERYSIPELAS OF VARYING SEVERITY |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 30.10.2018 | ||
| 500 | |a Date Revised 30.10.2018 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Erysipelas (PB) — a serious disease that is accompanied by severe complications and high lethality. The immunological investigations were carry out in 51 patients who were treated at the clinic for erysipelas with an immunomodulator application. Marked changes in the indices of phagocytic activity of monocytes (PHAM) and the cytokine profile in patients with erysipelas were note. Application in complex treatment ofimmunomodulator give the positive effect on the indices of PHAM | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Angiogenesis Inducing Agents |2 NLM | |
| 650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
| 650 | 7 | |a Anti-Inflammatory Agents |2 NLM | |
| 650 | 7 | |a Anticoagulants |2 NLM | |
| 650 | 7 | |a Histamine Antagonists |2 NLM | |
| 650 | 7 | |a Immunologic Factors |2 NLM | |
| 650 | 7 | |a Interleukins |2 NLM | |
| 650 | 7 | |a Tumor Necrosis Factor-alpha |2 NLM | |
| 700 | 1 | |a Shendrik, V G |e verfasserin |4 aut | |
| 700 | 1 | |a Kuznetsova, L V |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Klinichna khirurhiia |d 1993 |g (2016), 7 vom: 26., Seite 54-7 |w (DE-627)NLM085989835 |x 0023-2130 |7 nnns |
| 773 | 1 | 8 | |g year:2016 |g number:7 |g day:26 |g pages:54-7 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2016 |e 7 |b 26 |h 54-7 | ||